STOCK TITAN

[Form 4] Omega Healthcare Investors Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Codexis, Inc. (CDXS) received a Form 4 filing from Opaleye Management Inc., a 10% beneficial owner, detailing an open-market purchase completed on 27 June 2025.

  • Transaction: 100,000 shares of Codexis common stock were purchased (Code P) at an average price of $2.39 per share.
  • Post-transaction holdings: Opaleye now reports 12,350,000 shares held indirectly through Opaleye, L.P. and an additional 250,000 shares in a separately managed account, bringing total reported beneficial ownership to 12.6 million shares.
  • Ownership form: All shares are reported as indirect (Form I); the investment manager disclaims beneficial ownership beyond its pecuniary interest.
  • Reporting party status: Opaleye is classified as a 10% owner; no board or executive role is indicated.

The filing signals incremental insider accumulation by a large shareholder. While the 100 k-share purchase is modest relative to the 12.35 million-share position, fresh buying can be interpreted by investors as a vote of confidence in Codexis at current price levels. No derivative transactions, sales or options were disclosed in this filing.

Codexis, Inc. (CDXS) ha ricevuto una comunicazione Form 4 da parte di Opaleye Management Inc., un azionista con una partecipazione del 10%, che dettaglia un acquisto sul mercato aperto completato il 27 giugno 2025.

  • Transazione: 100.000 azioni ordinarie di Codexis sono state acquistate (Codice P) a un prezzo medio di 2,39 $ per azione.
  • Detenzione post-transazione: Opaleye dichiara ora di detenere indirettamente 12.350.000 azioni tramite Opaleye, L.P. e ulteriori 250.000 azioni in un conto gestito separatamente, portando la partecipazione totale dichiarata a 12,6 milioni di azioni.
  • Forma di proprietà: Tutte le azioni sono riportate come indirette (Modulo I); il gestore degli investimenti nega la titolarità effettiva al di là del proprio interesse pecuniario.
  • Stato del soggetto segnalante: Opaleye è classificata come un azionista con oltre il 10%; non è indicato alcun ruolo nel consiglio o esecutivo.

La comunicazione indica un accumulo incrementale di azioni da parte di un grande azionista interno. Sebbene l'acquisto di 100.000 azioni sia modesto rispetto alla posizione di 12,35 milioni di azioni, questo nuovo acquisto può essere interpretato dagli investitori come un segnale di fiducia in Codexis ai livelli di prezzo attuali. Non sono state dichiarate operazioni su derivati, vendite o opzioni in questa comunicazione.

Codexis, Inc. (CDXS) recibió una presentación del Formulario 4 por parte de Opaleye Management Inc., un propietario beneficiario del 10%, detallando una compra en el mercado abierto completada el 27 de junio de 2025.

  • Transacción: Se compraron 100,000 acciones ordinarias de Codexis (Código P) a un precio promedio de $2.39 por acción.
  • Posiciones tras la transacción: Opaleye reporta ahora la tenencia indirecta de 12,350,000 acciones a través de Opaleye, L.P. y otras 250,000 acciones en una cuenta gestionada por separado, sumando una propiedad beneficiaria total reportada de 12.6 millones de acciones.
  • Forma de propiedad: Todas las acciones se reportan como indirectas (Formulario I); el gestor de inversiones niega la propiedad beneficiaria más allá de su interés pecuniario.
  • Estado del reportante: Opaleye está clasificada como un propietario del 10%; no se indica ningún cargo en la junta o ejecutivo.

La presentación señala una acumulación incremental de acciones por parte de un gran accionista interno. Aunque la compra de 100,000 acciones es modesta en comparación con la posición de 12.35 millones de acciones, la compra reciente puede interpretarse por los inversores como un voto de confianza en Codexis a los niveles de precio actuales. No se divulgaron transacciones con derivados, ventas u opciones en esta presentación.

Codexis, Inc. (CDXS)는 10% 지분 보유자인 Opaleye Management Inc.로부터 2025년 6월 27일에 완료된 공개 시장 매수 내역을 상세히 기록한 Form 4 신고서를 받았습니다.

  • 거래 내역: Codexis 보통주 100,000주를 주당 평균 $2.39매수(코드 P)하였습니다.
  • 거래 후 보유 현황: Opaleye는 Opaleye, L.P.를 통해 간접적으로 12,350,000주를 보유하고 있으며, 별도로 관리되는 계좌에 250,000주를 추가로 보유하여 총 보고된 실질 소유 지분이 1,260만주에 이릅니다.
  • 소유 형태: 모든 주식은 간접 소유(Form I)로 신고되었으며, 투자 매니저는 금전적 이익을 넘어선 실질 소유권을 부인합니다.
  • 신고자 지위: Opaleye는 10% 소유자로 분류되며, 이사회 또는 경영진 역할은 명시되지 않았습니다.

이번 신고는 대주주에 의한 내부자 추가 매수를 나타냅니다. 100,000주 매수는 1,235만 주 보유 규모에 비해 적은 편이지만, 신규 매수는 투자자들 사이에서 현재 가격 수준에서 Codexis에 대한 신뢰의 표시로 해석될 수 있습니다. 본 신고서에는 파생상품 거래, 매도 또는 옵션 거래는 포함되지 않았습니다.

Codexis, Inc. (CDXS) a reçu un dépôt Formulaire 4 de la part de Opaleye Management Inc., un détenteur bénéficiaire à 10%, détaillant un achat sur le marché libre réalisé le 27 juin 2025.

  • Transaction : 100 000 actions ordinaires de Codexis ont été achetées (Code P) à un prix moyen de 2,39 $ par action.
  • Positions après transaction : Opaleye déclare désormais détenir indirectement 12 350 000 actions via Opaleye, L.P. et un compte géré séparément contenant 250 000 actions supplémentaires, portant la propriété bénéficiaire totale déclarée à 12,6 millions d’actions.
  • Forme de propriété : Toutes les actions sont déclarées comme indirectes (Formulaire I) ; le gestionnaire d’investissement décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire.
  • Statut du déclarant : Opaleye est classée comme un détenteur de 10% ; aucun rôle au conseil d’administration ou exécutif n’est indiqué.

Le dépôt indique une accumulation progressive d’actions par un grand actionnaire interne. Bien que l’achat de 100 000 actions soit modeste par rapport à la position de 12,35 millions d’actions, ce nouvel achat peut être interprété par les investisseurs comme un signe de confiance envers Codexis aux niveaux de prix actuels. Aucune transaction sur dérivés, vente ou option n’a été divulguée dans ce dépôt.

Codexis, Inc. (CDXS) erhielt eine Form-4-Meldung von Opaleye Management Inc., einem 10%-Eigentümer, die einen am 27. Juni 2025 abgeschlossenen Kauf am offenen Markt detailliert beschreibt.

  • Transaktion: 100.000 Aktien der Codexis-Stammaktien wurden zum Durchschnittspreis von 2,39 $ pro Aktie gekauft (Code P).
  • Bestand nach der Transaktion: Opaleye meldet nun indirekt gehaltene 12.350.000 Aktien über Opaleye, L.P. sowie weitere 250.000 Aktien in einem separat verwalteten Konto, was die insgesamt gemeldete wirtschaftliche Eigentümerschaft auf 12,6 Millionen Aktien erhöht.
  • Eigentumsform: Alle Aktien werden als indirekt (Formular I) gemeldet; der Investmentmanager lehnt eine wirtschaftliche Eigentümerschaft über sein pecuniäres Interesse hinaus ab.
  • Status der meldenden Partei: Opaleye wird als 10%-Eigentümer eingestuft; keine Vorstandsfunktion oder Leitungstätigkeit ist angegeben.

Die Meldung signalisiert eine schrittweise Insider-Akkumulation durch einen Großaktionär. Obwohl der Kauf von 100.000 Aktien im Vergleich zur Position von 12,35 Millionen Aktien gering ist, kann der frische Kauf von Investoren als Vertrauensbeweis in Codexis zu den aktuellen Kursniveaus interpretiert werden. In dieser Meldung wurden keine Derivatgeschäfte, Verkäufe oder Optionen offengelegt.

Positive
  • 10% owner purchased 100,000 shares at $2.39, signalling confidence and raising total indirect stake to 12.35 million shares.
Negative
  • None.

Insights

TL;DR 10% owner Opaleye adds 100 k shares, lifting indirect stake to 12.35 m; modest but positive insider-buy signal.

Analysis: The $2.39 purchase price sits near recent lows, implying the investor views shares as undervalued. Although the incremental buy represents less than 1% of Opaleye’s existing position, continued accumulation by a fund already above the 10% threshold can bolster market sentiment. No sales or hedges were reported, reducing concerns of near-term distribution. Absent earnings data, the purchase is a standalone bullish indicator rather than confirmation of fundamental improvement.

TL;DR Additional indirect insider purchase strengthens alignment but retains disclaimer of true beneficial ownership.

The filing underscores sustained economic exposure by Opaleye without altering governance dynamics—no board seat, no direct control. Indirect holding structure limits transparency, yet repeated open-market buying typically aligns interests with minority shareholders. The absence of derivative grants or preferential terms suggests market-rate acquisition, lowering agency-risk concerns. Overall governance impact: mildly positive.

Codexis, Inc. (CDXS) ha ricevuto una comunicazione Form 4 da parte di Opaleye Management Inc., un azionista con una partecipazione del 10%, che dettaglia un acquisto sul mercato aperto completato il 27 giugno 2025.

  • Transazione: 100.000 azioni ordinarie di Codexis sono state acquistate (Codice P) a un prezzo medio di 2,39 $ per azione.
  • Detenzione post-transazione: Opaleye dichiara ora di detenere indirettamente 12.350.000 azioni tramite Opaleye, L.P. e ulteriori 250.000 azioni in un conto gestito separatamente, portando la partecipazione totale dichiarata a 12,6 milioni di azioni.
  • Forma di proprietà: Tutte le azioni sono riportate come indirette (Modulo I); il gestore degli investimenti nega la titolarità effettiva al di là del proprio interesse pecuniario.
  • Stato del soggetto segnalante: Opaleye è classificata come un azionista con oltre il 10%; non è indicato alcun ruolo nel consiglio o esecutivo.

La comunicazione indica un accumulo incrementale di azioni da parte di un grande azionista interno. Sebbene l'acquisto di 100.000 azioni sia modesto rispetto alla posizione di 12,35 milioni di azioni, questo nuovo acquisto può essere interpretato dagli investitori come un segnale di fiducia in Codexis ai livelli di prezzo attuali. Non sono state dichiarate operazioni su derivati, vendite o opzioni in questa comunicazione.

Codexis, Inc. (CDXS) recibió una presentación del Formulario 4 por parte de Opaleye Management Inc., un propietario beneficiario del 10%, detallando una compra en el mercado abierto completada el 27 de junio de 2025.

  • Transacción: Se compraron 100,000 acciones ordinarias de Codexis (Código P) a un precio promedio de $2.39 por acción.
  • Posiciones tras la transacción: Opaleye reporta ahora la tenencia indirecta de 12,350,000 acciones a través de Opaleye, L.P. y otras 250,000 acciones en una cuenta gestionada por separado, sumando una propiedad beneficiaria total reportada de 12.6 millones de acciones.
  • Forma de propiedad: Todas las acciones se reportan como indirectas (Formulario I); el gestor de inversiones niega la propiedad beneficiaria más allá de su interés pecuniario.
  • Estado del reportante: Opaleye está clasificada como un propietario del 10%; no se indica ningún cargo en la junta o ejecutivo.

La presentación señala una acumulación incremental de acciones por parte de un gran accionista interno. Aunque la compra de 100,000 acciones es modesta en comparación con la posición de 12.35 millones de acciones, la compra reciente puede interpretarse por los inversores como un voto de confianza en Codexis a los niveles de precio actuales. No se divulgaron transacciones con derivados, ventas u opciones en esta presentación.

Codexis, Inc. (CDXS)는 10% 지분 보유자인 Opaleye Management Inc.로부터 2025년 6월 27일에 완료된 공개 시장 매수 내역을 상세히 기록한 Form 4 신고서를 받았습니다.

  • 거래 내역: Codexis 보통주 100,000주를 주당 평균 $2.39매수(코드 P)하였습니다.
  • 거래 후 보유 현황: Opaleye는 Opaleye, L.P.를 통해 간접적으로 12,350,000주를 보유하고 있으며, 별도로 관리되는 계좌에 250,000주를 추가로 보유하여 총 보고된 실질 소유 지분이 1,260만주에 이릅니다.
  • 소유 형태: 모든 주식은 간접 소유(Form I)로 신고되었으며, 투자 매니저는 금전적 이익을 넘어선 실질 소유권을 부인합니다.
  • 신고자 지위: Opaleye는 10% 소유자로 분류되며, 이사회 또는 경영진 역할은 명시되지 않았습니다.

이번 신고는 대주주에 의한 내부자 추가 매수를 나타냅니다. 100,000주 매수는 1,235만 주 보유 규모에 비해 적은 편이지만, 신규 매수는 투자자들 사이에서 현재 가격 수준에서 Codexis에 대한 신뢰의 표시로 해석될 수 있습니다. 본 신고서에는 파생상품 거래, 매도 또는 옵션 거래는 포함되지 않았습니다.

Codexis, Inc. (CDXS) a reçu un dépôt Formulaire 4 de la part de Opaleye Management Inc., un détenteur bénéficiaire à 10%, détaillant un achat sur le marché libre réalisé le 27 juin 2025.

  • Transaction : 100 000 actions ordinaires de Codexis ont été achetées (Code P) à un prix moyen de 2,39 $ par action.
  • Positions après transaction : Opaleye déclare désormais détenir indirectement 12 350 000 actions via Opaleye, L.P. et un compte géré séparément contenant 250 000 actions supplémentaires, portant la propriété bénéficiaire totale déclarée à 12,6 millions d’actions.
  • Forme de propriété : Toutes les actions sont déclarées comme indirectes (Formulaire I) ; le gestionnaire d’investissement décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire.
  • Statut du déclarant : Opaleye est classée comme un détenteur de 10% ; aucun rôle au conseil d’administration ou exécutif n’est indiqué.

Le dépôt indique une accumulation progressive d’actions par un grand actionnaire interne. Bien que l’achat de 100 000 actions soit modeste par rapport à la position de 12,35 millions d’actions, ce nouvel achat peut être interprété par les investisseurs comme un signe de confiance envers Codexis aux niveaux de prix actuels. Aucune transaction sur dérivés, vente ou option n’a été divulguée dans ce dépôt.

Codexis, Inc. (CDXS) erhielt eine Form-4-Meldung von Opaleye Management Inc., einem 10%-Eigentümer, die einen am 27. Juni 2025 abgeschlossenen Kauf am offenen Markt detailliert beschreibt.

  • Transaktion: 100.000 Aktien der Codexis-Stammaktien wurden zum Durchschnittspreis von 2,39 $ pro Aktie gekauft (Code P).
  • Bestand nach der Transaktion: Opaleye meldet nun indirekt gehaltene 12.350.000 Aktien über Opaleye, L.P. sowie weitere 250.000 Aktien in einem separat verwalteten Konto, was die insgesamt gemeldete wirtschaftliche Eigentümerschaft auf 12,6 Millionen Aktien erhöht.
  • Eigentumsform: Alle Aktien werden als indirekt (Formular I) gemeldet; der Investmentmanager lehnt eine wirtschaftliche Eigentümerschaft über sein pecuniäres Interesse hinaus ab.
  • Status der meldenden Partei: Opaleye wird als 10%-Eigentümer eingestuft; keine Vorstandsfunktion oder Leitungstätigkeit ist angegeben.

Die Meldung signalisiert eine schrittweise Insider-Akkumulation durch einen Großaktionär. Obwohl der Kauf von 100.000 Aktien im Vergleich zur Position von 12,35 Millionen Aktien gering ist, kann der frische Kauf von Investoren als Vertrauensbeweis in Codexis zu den aktuellen Kursniveaus interpretiert werden. In dieser Meldung wurden keine Derivatgeschäfte, Verkäufe oder Optionen offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gupta Vikas

(Last) (First) (Middle)
303 INTERNATIONAL CIRCLE
SUITE 200

(Street)
HUNT VALLEY MD 21030

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Investment Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Profits Interest Units (1)(2) 06/30/2025 M 11,627 (3) (3) OP Units 11,627 $0 107,025 D
Profits Interest Units (1)(2) 06/30/2025 M 12,042 (4) (4) OP Units 12,042 $0 94,983 D
OP Units (2) 06/30/2025 M 11,627 (2) (2) Common Stock 11,627 $0 130,717 D
OP Units (2) 06/30/2025 M 12,042 (2) (2) Common Stock 12,042 $0 142,759 D
Explanation of Responses:
1. Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.
2. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.
3. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Absolute Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
4. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Relative Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
/s/ Meghan C. Lyons, Attorney-in-Fact 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Codexis (CDXS) shares did Opaleye buy on 27 June 2025?

100,000 shares of common stock were purchased.

What was the purchase price for the insider transaction in CDXS?

The shares were acquired at $2.39 per share.

What is Opaleye’s total reported ownership in Codexis after the transaction?

Opaleye reports 12,350,000 shares via Opaleye, L.P. plus 250,000 in a managed account.

Did the Form 4 include any stock sales or derivative transactions?

No. The filing discloses only a purchase of common stock and reports no derivatives or sales.

Why is Opaleye considered a 10% owner of Codexis?

Its aggregated indirect holdings exceed 10% of Codexis’ outstanding common stock, triggering Section 16 reporting.
Omega Healthcare

NYSE:OHI

OHI Rankings

OHI Latest News

OHI Latest SEC Filings

OHI Stock Data

10.64B
288.76M
0.21%
77.4%
5.42%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
HUNT VALLEY